GPC3 and hepatocellular carcinoma: The results of a phase I study exploring fourth-generation CAR T-cells targeting GPC3 (4G-CAR-GPC3 T-cells) for advanced HCC were shared at the ASCO GI cancers 2021 annual meeting.